Really people?

I am a "numbers" person . This gives good statistics (p=0.0329) and has a good number of patients (power).

I would look at the secondary end-points and, if favourable, will stop the test and approve Leronlimab.

However, I suspect that there were more deaths all together (without knowing which group from).